keyword
https://read.qxmd.com/read/38398290/recent-treatment-strategies-for-acute-pancreatitis
#1
REVIEW
Yongcook Song, Sang-Hoon Lee
Acute pancreatitis (AP) is a leading gastrointestinal disease that causes hospitalization. Initial management in the first 72 h after the diagnosis of AP is pivotal, which can influence the clinical outcomes of the disease. Initial management, including assessment of disease severity, fluid resuscitation, pain control, nutritional support, antibiotic use, and endoscopic retrograde cholangiopancreatography (ERCP) in gallstone pancreatitis, plays a fundamental role in AP treatment. Recent updates for fluid resuscitation, including treatment goals, the type, rate, volume, and duration, have triggered a paradigm shift from aggressive hydration with normal saline to goal-directed and non-aggressive hydration with lactated Ringer's solution...
February 8, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/37505932/frequent-guidewire-passage-into-the-pancreatic-duct-is-an-independent-risk-factor-for-post-endoscopic-retrograde-cholangiopancreatography-ercp-pancreatitis-pep-among-high-risk-individuals-a-post-hoc-analysis-of-a-randomized-controlled-trial-data
#2
JOURNAL ARTICLE
Mahesh K Goenka, Venkata S Akshintala, Ayesha Kamal, Furqan A Bhullar, Nikhil Bush, Vijay Kumar, Madhurima Chakraborty, Merve Gurakar, Sundeep Lakhtakia, Rupjyoti Talukdar, Guru Trikudanathan, Mouen A Khashab, Anthony N Kalloo, D Nageshwar Reddy, Saroj K Sinha, Vikesh K Singh, Rakesh Kochhar
BACKGROUND: There have been no studies that have systematically evaluated whether previously validated patient and procedural risk factors for PEP remain significant in patients receiving rectal indomethacin. METHODS: Data from a randomized controlled trial (RCT) of high-risk patients undergoing ERCP who received rectal indomethacin with or without topical epinephrine was evaluated. PEP was defined using the consensus criteria definition. Pancreatic stenting was excluded to avoid confounding results with the role of epinephrine spray...
July 28, 2023: Journal of Digestive Diseases
https://read.qxmd.com/read/37125072/the-safety-and-efficacy-of-ringer-s-solution-loading-with-rectal-diclofenac-for-prevention-of-post-endoscopic-retrograde-cholangiopancreatography-pancreatitis-the-resolution-pep-study
#3
JOURNAL ARTICLE
Aiji Hattori, Reiko Yamada, Toji Murabayashi, Shinya Sugimoto, Hajime Imai, Keiichiro Nojiri, Naoki Kuroda, Shunsuke Tano, Hiroki Tanaka, Shimpei Matsusaki, Kenichiro Nishikawa, Hiroaki Naota, Isao Moritani, Kazunari Kurata, Toshitaka Fukui, Kyosuke Tanaka, Hayato Nakagawa
OBJECTIVES: We evaluated the safety and efficacy of aggressive hydration with rectal non-steroidal anti-inflammatory drugs for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). METHODS: This prospective, single-arm, multicenter trial was conducted at 12 institutions between October 2020 and August 2021. We enrolled 231 patients who had intact papillae and were scheduled to undergo ERCP. All patients were administered rectal diclofenac before ERCP...
April 2023: DEN Open
https://read.qxmd.com/read/36727757/update-on-the-management-of-acute-pancreatitis
#4
REVIEW
Fons F van den Berg, Marja A Boermeester
PURPOSE OF REVIEW: This review provides insight into the recent advancements in the management of acute pancreatitis. RECENT FINDINGS: Moderate fluid resuscitation and Ringer's lactate has advantages above aggressive fluid resuscitation and normal saline, respectively. A normal "on-demand" diet has a positive effect on recovery from acute pancreatitis and length of hospital stay. A multimodal pain management approach including epidural analgesia might reduce unwarranted effects of opiate use...
April 1, 2023: Current Opinion in Critical Care
https://read.qxmd.com/read/36508009/aggressive-hydration-for-preventing-post-endoscopic-retrograde-cholangiopancreatography-pancreatitis-trial-sequential-analysis
#5
JOURNAL ARTICLE
Tae Young Park, Hyun Kang, Geun Joo Choi, Hyoung-Chul Oh
BACKGROUND: Randomized controlled trials (RCTs) have demonstrated that aggressive hydration with lactated Ringer's (LR) solution reduces the frequency and severity of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). In this trial sequential analysis (TSA), we aimed to evaluate the prophylactic effect of aggressive hydration on PEP in specific patient subgroups and to determine the need for additional RCTs. METHODS: We conducted a systematic and comprehensive search to identify all randomized controlled studies published through August 2021 that examined the effectiveness of aggressive hydration for preventing PEP...
December 12, 2022: Surgical Endoscopy
https://read.qxmd.com/read/36349478/pre-emptive-hydration-with-lactated-ringer-s-solution-could-reduce-the-incidence-of-post-endoscopic-retrograde-cholangiopancreatography-pancreatitis-in-at-risk-patients-propensity-score-matched-analysis
#6
JOURNAL ARTICLE
Yusuke Kurita, Ko Suzuki, Shin Yagi, Sho Hasegawa, Takamitsu Sato, Kunihiro Hosono, Noritoshi Kobayashi, Itaru Endo, Kensuke Kubota, Atsushi Nakajima
BACKGROUND/PURPOSE: This study aimed to investigate the efficacy of intensive fluid-loading therapy post-endoscopic retrograde cholangiopancreatography (ERCP) for the prevention of post-ERCP pancreatitis (PEP) in at-risk patients. METHODS: In this retrospective study, data of 1200 patients at risk for PEP were investigated. After propensity score matching, 404 patients were included in the normal (n = 202) and hydration (n = 202) groups. On the day of ERCP, patients in both groups were infused with 2000 ml/24 h of fluid before ERCP...
June 2023: Journal of Hepato-biliary-pancreatic Sciences
https://read.qxmd.com/read/35845031/efficacy-of-aggressive-hydration-with-normal-saline-versus-lactated-ringer-s-solution-for-the-prevention-of-post-ercp-pancreatitis-in-high-risk-patients-a-randomized-controlled-trial
#7
JOURNAL ARTICLE
Rupal Patel, Carlos Bertran-Rodriguez, Ambuj Kumar, Patrick Brady, Rene Gomez-Esquivel, Kinesh Changela, Negar Niknam, Pushpak Taunk
Background and study aims  Post-ERCP pancreatitis (PEP) is a common adverse event in high-risk patients. Current intervention known to reduce the incidence and severity of PEP include pancreatic duct stent placement, nonsteroidal anti-inflammatory drugs per rectum, and intravenous (IV) fluids. We compared aggressive normal saline (NS) vs aggressive lactated Ringer's (LR) infusion for the prevention of PEP in high-risk patients undergoing ERCP. Patients and methods  Patients were randomized to receive either an aggressive infusion of NS or LR...
July 2022: Endoscopy International Open
https://read.qxmd.com/read/35610548/-the-latest-knowledge-on-endoscopic-retrograde-cholangiopancreatography-related-pancreatitis
#8
REVIEW
Chang-Hwan Park
ERCP has been established as a golden diagnostic and therapeutic modality in various pancreatobiliary diseases, including gallstones and malignancy. On the other hand, ERCP is a relatively invasive procedure with radiation hazards and major complications. Among the major complications, ERCP-related pancreatitis has been reported in more than 14.7% of high-risk patients, which might lead to extended hospitalization and a substantial burden for both patients and physicians. Recent guidelines have defined the high-risk factors for ERCP-related pancreatitis...
May 25, 2022: Korean Journal of Gastroenterology, Taehan Sohwagi Hakhoe Chi
https://read.qxmd.com/read/35470300/an-open-label-randomized-controlled-trial-comparing-effectiveness-of-aggressive-hydration-versus-high-dose-rectal-indomethacin-in-the-prevention-of-postendoscopic-retrograde-cholangiopancreatographic-pancreatitis-ahri-pep
#9
JOURNAL ARTICLE
Pradipta Guha, Partha S Patra, Debashis Misra, Sk Mahiuddin Ahammed, Rajib Sarkar, Gopal K Dhali, Sukanta Ray, Kshaunish Das
BACKGROUND: Although rectal administration of nonsteroidal anti-inflammatory drugs is recommended as the standard pharmacologic modality to prevent postendoscopic retrograde cholangiopancreatography (ERCP) post-ERCP pancreatitis (PEP), vigorous periprocedural hydration (vHR) with lactated Ringer's solution (LR) is emerging as an effective prophylaxis modality for PEP. There has been no head-to-head comparison between these 2. STUDY: This was a single-center, randomized, open-label, noninferiority, parallel-assigned, equal allocation, controlled clinical trial in a tertiary care hospital...
April 21, 2022: Journal of Clinical Gastroenterology
https://read.qxmd.com/read/35412495/nsaids-are-not-enough-a-double-blinded-randomized-controlled-trial-on-the-impact-of-intensive-hydration-for-the-prevention-of-post-endoscopic-retrograde-cholangiopancreatography-pancreatitis
#10
RANDOMIZED CONTROLLED TRIAL
Pedro Boal Carvalho, Joana Magalhães, Francisca Dias de Castro, Tiago Cúrdia Gonçalves, Sara Monteiro, Sofia Xavier, Bruno Rosa, José Cotter
BACKGROUND: Pancreatitis is the most common complication following endoscopic retrograde cholangiopancreatography (ERCP). In patients receiving NSAID prophylaxis, we aimed to assess whether periprocedural intensive hydration (IH) resulted in a lower incidence of PEP when compared to standard hydration (SH). MATERIAL AND METHODS: Prospective, single-center, double-blinded randomized controlled trial, with inclusion of consecutive patients submitted to inaugural ERCP between January 2015 and December 2018...
July 1, 2022: European Journal of Gastroenterology & Hepatology
https://read.qxmd.com/read/34714289/is-the-combination-of-rectal-diclofenac-and-intravenous-ringer-lactate-superior-to-individual-therapy-for-prophylaxis-of-post-endoscopic-retrograde-cholangiopancreatography-pancreatitis-a-prospective-open-label-single-center-randomized-trial
#11
RANDOMIZED CONTROLLED TRIAL
Ravi Thanage, Shubham Jain, Sanjay Chandnani, Suhas Udgirkar, Sujit Nair, Prasanta Debnath, Samit Jain, Pravin Rathi
METHODS: This was single-center, open-label, randomized trial. Patients who were undergoing ERCP and who were at high risk for the development of PEP were selected for the study. Patients were randomized into 3 treatment groups: diclofenac suppository group, RL group, and a combination group. RESULTS: Eight of 57 patients (14.03%) in the diclofenac group, 9 of 57 patients (15.78%) in the RL group, and 6 of 57 patients (10.52%) in the combination group developed PEP...
September 1, 2021: Pancreas
https://read.qxmd.com/read/34655014/continuous-infusion-of-fluid-hydration-over-24-hours-does-not-prevent-post-endoscopic-retrograde-cholangiopancreatography-pancreatitis
#12
RANDOMIZED CONTROLLED TRIAL
Arunchai Chang, Nonthalee Pausawasdi, Phunchai Charatcharoenwitthaya, Uayporn Kaosombatwattana, Tassanee Sriprayoon, Julajak Limsrivilai, Varayu Prachayakul, Somchai Leelakusolvong
BACKGROUND: Aggressive intravenous fluid hydration, by administering 3500 mL of lactated Ringer's solution (LRS) in 9 h with a peri-procedural bolus, reduces post-ERCP pancreatitis (PEP) incidence. A concern of this strategy is adverse events related to volume overload; however, the impact of fluid hydration over an extended period without a bolus on PEP is unknown. AIM: To assess the effect of continuous infusion of high-volume fluid at a constant rate over 24 h on PEP incidence and severity...
August 2022: Digestive Diseases and Sciences
https://read.qxmd.com/read/34481952/a-cost-effectiveness-analysis-for-post-endoscopic-retrograde-cholangiopancreatography-pancreatitis-prophylaxis-in-the-united-states
#13
JOURNAL ARTICLE
Nikhil R Thiruvengadam, Monica Saumoy, Yecheskel Schneider, Sara Attala, Joseph Triggs, Peter Lee, Michael L Kochman
BACKGROUND & AIMS: Post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is the most common adverse event after endoscopic retrograde cholangiopancreatography, and is responsible for substantial morbidity and health care expenditures of at least $200 million. Therapies for PEP prevention include pancreatic stent placement (PSP), rectal indomethacin, sublingual nitrates, and aggressive lactated Ringer's hydration. Our objective was to determine which PEP prophylactic strategies are cost effective...
January 2022: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/34353727/combined-use-of-indomethacin-and-hydration-is-the-best-conservative-approach-for-post-ercp-pancreatitis-prevention-a-network-meta-analysis
#14
JOURNAL ARTICLE
Katalin Márta, Noémi Gede, Zsolt Szakács, Margit Solymár, Péter Jenő Hegyi, Bálint Tél, Bálint Erőss, Áron Vincze, Marianna Arvanitakis, Ivo Boškoski, Marco J Bruno, Péter Hegyi
OBJECTIVES: Post-ERCP pancreatitis (PEP) is a life-threatening complication. Given the lack of a causative treatment for pancreatitis, it is of vital importance to minimize this risk of PEP. Multi-target preventive therapy may be the best choice for PEP prevention as disease development is multifactorial. AIM: We aimed to assess the efficacy of a combination of indomethacin and hydration - type and amount - for PEP prevention via a network meta-analysis. METHODS: Through a systematic search in three databases, we searched all randomized controlled trials involving hydration and indomethacin and ranked the PEP preventive efficacy with a Bayesian network meta-analysis using the PRISMA for Network Meta-Analyses (PRISMA-NMA) guideline...
October 2021: Pancreatology: Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]
https://read.qxmd.com/read/34214449/non-steroidal-anti-inflammatory-drugs-intravenous-fluids-pancreatic-stents-or-their-combinations-for-the-prevention-of-post-endoscopic-retrograde-cholangiopancreatography-pancreatitis-a-systematic-review-and-network-meta-analysis
#15
JOURNAL ARTICLE
Venkata S Akshintala, Christina J Sperna Weiland, Furqan A Bhullar, Ayesha Kamal, Kavin Kanthasamy, Albert Kuo, Cristian Tomasetti, Merve Gurakar, Joost P H Drenth, Dhiraj Yadav, B Joseph Elmunzer, D Nageshwar Reddy, Mahesh K Goenka, Rakesh Kochhar, Anthony N Kalloo, Mouen A Khashab, Erwin J M van Geenen, Vikesh K Singh
BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs), intravenous fluid, pancreatic stents, or combinations of these have been evaluated in randomised controlled trials (RCTs) for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis, but the comparative efficacy of these treatments remains unclear. Our aim was to do an exploratory network meta-analysis of previous RCTs to systematically compare the direct and indirect evidence and rank NSAIDs, intravenous fluids, pancreatic stents, or combinations of these to determine the most efficacious method of prophylaxis for post-ERCP pancreatitis...
September 2021: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/34109084/aggressive-hydration-with-ringer-s-lactate-in-the-prevention-of-post-ercp-pancreatitis-a-meta-analysis
#16
REVIEW
Samar Aljohani, Hyder Mirghani
Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is a dangerous complication and occurs in a considerable number of patients. However, since well-randomized controlled trials investigating aggressive hydration with Ringer's lactate are lacking, this meta-analysis assessed the role of aggressive hydration with Ringer's lactate alone or in combination with other therapies in the prevention of PEP. We searched PubMed, Cochrane Library, and Google Scholar for relevant articles. The search engine was set to randomize controlled trials and prospective cohorts assessing Ringer's lactate in PEP prevention either alone or in combination with non-steroidal anti-inflammatory drugs (NSAIDs) and stent...
May 7, 2021: Curēus
https://read.qxmd.com/read/33879722/aggressive-hydration-with-lactated-ringer-solution-in-prevention-of-post-endoscopic-retrograde-cholangiopancreatography-pancreatitis-a-systematic-review-and-meta-analysis
#17
JOURNAL ARTICLE
Mengmeng Wu, Shuaiyu Jiang, Xiaoguang Lu, Yilong Zhong, Yi Song, Zhiwei Fan, Xin Kang
BACKGROUND: Acute pancreatitis is the most common complication of Endoscopic Retrograde Cholangiopancreatography (ERCP). There was no conclusion on the prevention of Post-ERCP Pancreatitis (PEP) by Lactated Ringer Solution. AIM: The purpose of this meta analyses is to determine whether aggressive hydration with Lactated Ringer Solution reduced the incidence of PEP. METHODS: We retrieved randomized clinical trials comparing the preventive effects of aggressive hydration with Lactated Ringer Solution and standard hydration on PEP from PubMed, the Cochrane Library, Embase, the Web of Science, Clinical Trial...
April 23, 2021: Medicine (Baltimore)
https://read.qxmd.com/read/33740415/aggressive-fluid-hydration-plus-non-steroidal-anti-inflammatory-drugs-versus-non-steroidal-anti-inflammatory-drugs-alone-for-post-endoscopic-retrograde-cholangiopancreatography-pancreatitis-fluyt-a-multicentre-open-label-randomised-controlled-trial
#18
RANDOMIZED CONTROLLED TRIAL
Christina J Sperna Weiland, Xavier J N M Smeets, Wietske Kievit, Robert C Verdonk, Alexander C Poen, Abha Bhalla, Niels G Venneman, Ben J M Witteman, David W da Costa, Brechje C van Eijck, Matthijs P Schwartz, Tessa E H Römkens, Jan Maarten Vrolijk, Muhammed Hadithi, Annet M C J Voorburg, Lubbertus C Baak, Willem J Thijs, Roy L van Wanrooij, Adriaan C I T L Tan, Tom C J Seerden, Yolande C A Keulemans, Thomas R de Wijkerslooth, Wim van de Vrie, Peter van der Schaar, Sven M van Dijk, Nora D L Hallensleben, Ruud L Sperna Weiland, Hester C Timmerhuis, Devica S Umans, Jeanin E van Hooft, Harry van Goor, Hjalmar C van Santvoort, Marc G Besselink, Marco J Bruno, Paul Fockens, Joost P H Drenth, Erwin J M van Geenen
BACKGROUND: Pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Prophylactic rectal administration of non-steroidal anti-inflammatory drugs (NSAIDs) is considered as standard of care to reduce the risk of post-ERCP pancreatitis. It has been suggested that aggressive hydration might further reduce this risk. Guidelines already recommend aggressive hydration in patients who are unable to receive rectal NSAIDs, although it is laborious and time consuming...
May 2021: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/33188441/emerging-therapies-to-prevent-post-ercp-pancreatitis
#19
REVIEW
Nikhil R Thiruvengadam, Michael L Kochman
PURPOSE OF REVIEW: The aim of this review is to evaluate emerging, novel therapies for the prevention of post-ERCP pancreatitis. RECENT FINDINGS: Rectal indomethacin reduces the risk of pancreatitis in low- and average-risk patients, who comprise the majority of patients undergoing ERCP. An 8-h protocol of aggressive lactated Ringer's reduces the risk of pancreatitis in average-risk patients. Sublingual nitrate may provide additional benefit to rectal NSAIDs in preventing PEP...
November 13, 2020: Current Gastroenterology Reports
https://read.qxmd.com/read/33068083/ringer-s-lactate-hydration-and-incidence-of-post-ercp-pancreatitis-a-descriptive-cross-sectional-study
#20
JOURNAL ARTICLE
Ashis Pun, Amit Dhungana, Dipendra Neupane
INTRODUCTION: Endoscopic retrograde cholangiopancreatography is one of the most frequently used treatment modality for various pancreatobiliary problems. Frequent complications of endoscopic retrograde cholangiopancreatography include pancreatitis, cholangitis, hemorrhage and perforation. This study was done to see the prevalence of post endoscopic retrograde cholangiopancreatography pancreatitis in patient aggressively hydrated with Ringer's Lactate solution. METHODS: A descriptive cross sectional study was carried out on patient undergoing endoscopic retrograde cholangiopancreatography at Bharatpur Hospital from June 2018 to August 2020...
September 27, 2020: JNMA; Journal of the Nepal Medical Association
keyword
keyword
169162
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.